Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Punjab, Similar States See Benefits From India Tax Cut

This article was originally published in PharmAsia News

Executive Summary

The Indian state of Punjab is expected to be one of the beneficiaries of the federal government's decision to reduce by half the excise duty on drugs. Currently, other states have tax-exempt status, and the planned excise-tax reduction is expected by Punjab and similar states to give them more equality and make them more attractive to drug manufacturers. Some states expect a relocation of some company drug units into non-exempt states. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068060

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel